Absci Corporation Common Stock
Veridion Score
Composite trend over time
Why is ABSI moving today?
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for ABSI.
ABSI insider activity
Absci Corporation Common Stock
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for ABSI.
ABSI contract awards, year to date.
Public federal awards linked to this ticker.
ABSI lobbying filings, year to date.
Registered lobbying filings matched to Absci Corporation Common Stock.